317:30-5-95.30. Medical necessity criteria for Acute II and PRTF continued stay for children
For continued stay in Acute II and PRTF programs, members must meet the terms and conditions contained in (1), (2), (3), (4), and either (5) or (6) of this subsection:
(1) A primary diagnosis from the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) with the exception of V codes, adjustment disorders, and substance abuse-related disorders, accompanied by detailed symptoms supporting the diagnosis. In lieu of a qualifying primary diagnosis, members eighteen (18) to twenty (20) years of age may have a secondary diagnosis of any personality disorder.
(2) Conditions are directly attributed to a psychiatric disorder as the primary reason for continued stay (this does not include placement issues, criminal behavior, or status offenses).
(3) There is documented continuing need for twenty-four (24) hour observation and treatment as evidenced by:
(A) Intensive behavioral management.
(B) Intensive treatment with the family/guardian and child in a structured milieu.
(C) Intensive treatment in preparation for re-entry into community.
(4) Documented efforts of working with child's family, legal guardian and/or custodian and other human service agencies toward a tentative discharge date.
(5) Patient is making measurable progress toward the treatment objectives specified in the treatment plan.
(A) Progress is measured in behavioral terms and reflected in the patient's treatment and discharge plans.
(B) Patient has made gains toward social responsibility and independence.
(C) There is active, ongoing psychiatric treatment and documented progress toward the treatment objective and discharge.
(D) There are documented efforts and evidence of active involvement with the family, guardian, child welfare worker, extended family, etc.
(6) Child's condition has remained unchanged or worsened.
(A) Documentation of regression is measured in behavioral terms and reflected in the patient's treatment and discharge plans.
(B) If condition is unchanged, there is evidence of re-evaluation of the treatment objectives and therapeutic interventions.